| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
- |
lung adenocarcinoma |
UGGT2 |
miR-578, miR-633 |
Q
S
M
| DN |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
circUGGT2 |
hepatocellular carcinoma |
UGGT2 |
miR-526b-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
circ_0008274 |
hepatocellular carcinoma |
UGGT2 |
miR-140-3p |
Q
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
- |
lung adenocarcinoma |
UGGT2 |
miR-578 |
Q
| DN |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
- |
lung adenocarcinoma |
UGGT2 |
- |
M
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
circUGGT2 |
urinary bladder carcinoma |
UGGT2 |
- |
Q
M
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0030632 |
circUGGT2 |
gastric cancer |
UGGT2 |
miR-186-3p |
Q
H
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0101050 |
circ_0101050 / circ_ 0,101,050 |
malignant colon neoplasm |
UGGT2 |
miR-140-3p |
Q
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
- |
lung cancer |
UGGT2 |
- |
Q
| DN |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0101050 |
- |
thyroid gland papillary carcinoma |
UGGT2 |
- |
Q
M
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
hsa_circRNA_101287 |
hepatocellular carcinoma |
UGGT2 |
hsa-miR-377-3p |
M
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0030632 |
- |
colorectal cancer |
UGGT2 |
hsa-miR-664b-3p, hsa-miR-139-5p, hsa-miR-6509-5p, hsa-miR-323a-3p, hsa-miR-370-3p, hsa-miR-181a-5p, hsa-miR-181b-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_UGGT2 |
hsa_circ_0008274 |
circ_0008274 |
thyroid gland papillary carcinoma |
UGGT2 |
- |
Q
M
| UP |
More |